{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:02:00Z","timestamp":1789207320863,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gender Medicine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.genm.2011.03.008","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T11:44:02Z","timestamp":1304336642000},"page":"57-68","source":"Crossref","is-referenced-by-count":17,"title":["Treating Menopausal Symptoms With a Tissue-Selective Estrogen Complex"],"prefix":"10.1016","volume":"8","author":[{"given":"Jeffrey P.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genm.2011.03.008_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.1990.tb30316.x","article-title":"Hot flashes: epidemiology and physiology","volume":"592","author":"Kronenberg","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.genm.2011.03.008_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nur.4770080308","article-title":"The prevalence of hot flash and associated variables among perimenopausal women","volume":"8","author":"Feldman","year":"1985","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.genm.2011.03.008_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200205000-00003","article-title":"A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century","volume":"9","author":"R\u00f6dstr\u00f6m","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.maturitas.2005.03.012","article-title":"Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens\/medroxyprogesterone acetate: The Pan-Asia menopause (PAM) study","volume":"52","author":"Haines","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.genm.2011.03.008_bib5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jama.1981.03310420031025","article-title":"Association of waking episodes with menopausal hot flushes","volume":"245","author":"Erlik","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.genm.2011.03.008_bib6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archinte.166.12.1262","article-title":"Severe hot flashes are associated with chronic insomnia","volume":"166","author":"Ohayon","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.genm.2011.03.008_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0029-7844(00)00930-3","article-title":"A prospective population-based study of menopausal symptoms","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.genm.2011.03.008_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s001920170074","article-title":"Urogenital prolapse and atrophy at menopause: a prevalence study","volume":"12","author":"Versi","year":"2001","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.genm.2011.03.008_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S8756-3282(02)00678-6","article-title":"Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent","volume":"30","author":"Bjarnason","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.genm.2011.03.008_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1471-0528.1989.tb03260.x","article-title":"The pathophysiology of peri- and postmenopausal bone loss","volume":"96","author":"Nilas","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.genm.2011.03.008_bib11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jbmr.5650070902","article-title":"Perspective","volume":"7","author":"Melton","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.genm.2011.03.008_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.genm.2011.03.008_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1359\/JBMR.040215","article-title":"Risk factors for incident vertebral fractures in men and women: the Rotterdam Study","volume":"19","author":"van der","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.genm.2011.03.008_bib14","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2008.19.6253","article-title":"Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis","volume":"27","author":"Loprinzi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.genm.2011.03.008_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.genm.2011.03.008_bib16","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.genm.2011.03.008_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.GME.0000108177.85442.71","article-title":"Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society","volume":"11","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","article-title":"Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society","volume":"17","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1359\/jbmr.060312","article-title":"Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.genm.2011.03.008_bib20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.genm.2011.03.008_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/gme.0b013e31817b076a","article-title":"Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society","volume":"15","author":"Utian","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2008.11.023","article-title":"Progestogens and brain: an update","volume":"62","author":"Pluchino","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.genm.2011.03.008_bib23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.maturitas.2008.10.008","article-title":"Progesterone, progestogens and psychosomatic health of the climacteric woman","volume":"62","author":"Bitzer","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.genm.2011.03.008_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1037\/1064-1297.15.5.427","article-title":"Progesterone: review of safety for clinical studies","volume":"15","author":"Goletiani","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.genm.2011.03.008_bib25","series-title":"Clinical Gynecologic Endocrinology and Infertility","author":"Speroff","year":"2005"},{"key":"10.1016\/j.genm.2011.03.008_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.maturitas.2005.06.003","article-title":"Changes in women's attitudes towards and use of hormone therapy after HERS and WHI","volume":"52","author":"Hoffmann","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.genm.2011.03.008_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.GME.0000148644.55486.36","article-title":"Hormone use and patient concerns after the findings of the Women's Health Initiative","volume":"12","author":"Rolnick","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.gme.0000233169.65045.b1","article-title":"Changing use of hormone therapy among minority women since the Women's Health Initiative","volume":"14","author":"Helenius","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.maturitas.2005.06.008","article-title":"Menopausal symptoms after cessation of hormone replacement therapy","volume":"53","author":"Ness","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.genm.2011.03.008_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/gme.0b013e318051718c","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0889-8529(02)00079-8","article-title":"Bisphosphonates","volume":"32","author":"McClung","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.genm.2011.03.008_bib32","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.genm.2011.03.008_bib33","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00198-009-1134-4","article-title":"Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis","volume":"21","author":"Imaz","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.genm.2011.03.008_bib34","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1517\/14656560903140533","article-title":"Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence","volume":"10","author":"Rabenda","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.genm.2011.03.008_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.genm.2011.03.008_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.genm.2011.03.008_bib37","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.genm.2011.03.008_bib38","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.genm.2011.03.008_bib39","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1177\/1933719108325759","article-title":"A new approach to menopausal therapy: the tissue selective estrogen complex","volume":"15","author":"Komm","year":"2008","journal-title":"Reprod Sci"},{"key":"10.1016\/j.genm.2011.03.008_bib40","series-title":"Evista\u00ae","year":"2007"},{"key":"10.1016\/j.genm.2011.03.008_bib41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.genm.2011.03.008_bib42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens (BZA\/CE) for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.genm.2011.03.008_bib43","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.genm.2011.03.008_bib44","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2009.05.093","article-title":"Bazedoxifene\/conjugated estrogens (BZA\/CE): incidence of uterine bleeding in postmenopausal women","volume":"92","author":"Archer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.genm.2011.03.008_bib45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/gme.0b013e3181a7df0d","article-title":"Relief of vasomotor symptoms with the tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens: a randomized, controlled trial","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens (BZA\/CE) for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.maturitas.2009.06.006","article-title":"Bazedoxifene\/conjugated estrogens and quality of life in postmenopausal women","volume":"63","author":"Utian","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.genm.2011.03.008_bib48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13697130903305627","article-title":"Effects of bazedoxifene\/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar\/vaginal atrophy","volume":"13","author":"Bachmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.genm.2011.03.008_bib49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1341-8076.2003.00132.x","article-title":"Compliance with hormone replacement therapy at Songklanagarind Hospital","volume":"29","author":"Wattanakumtornkul","year":"2003","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.genm.2011.03.008_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-5122(02)00341-9","article-title":"Compliance with hormone replacement therapy in Thai women","volume":"44","author":"Manonai","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.genm.2011.03.008_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0015-0282(01)01828-3","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"76","author":"Pickar","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.genm.2011.03.008_bib52","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0015-0282(03)01167-1","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.genm.2011.03.008_bib53","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/GME.0b013e318031a83d","article-title":"The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety","volume":"14","author":"Stovall","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.GME.0000087981.28957.CF","article-title":"Transition from estrogen therapy to raloxifene in postmenopausal women: Effects on treatment satisfaction and the endometrium-a pilot study","volume":"11","author":"Davis","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.genm.2011.03.008_bib55","first-page":"93","article-title":"Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses","volume":"52","author":"Carranza-Lira","year":"2007","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.genm.2011.03.008_bib56","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding","volume":"75","author":"Archer","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.genm.2011.03.008_bib57","first-page":"686","article-title":"Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate","volume":"83","author":"Archer","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.genm.2011.03.008_bib58","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.genm.2011.03.008_bib59","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archinte.166.15.1578","article-title":"Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy","volume":"166","author":"Crandall","year":"2006","journal-title":"Arch Intern Med"}],"container-title":["Gender Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550857911000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550857911000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T12:40:52Z","timestamp":1637584852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550857911000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1550857911000386"],"URL":"https:\/\/doi.org\/10.1016\/j.genm.2011.03.008","relation":{},"ISSN":["1550-8579"],"issn-type":[{"value":"1550-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}